dipyridamole is effective in preventing the thromboembolic complications of prosthetic heart valves and sulfinpyrazone reduces occlusive events in a-v silastic cannulae , while clofibrate is clearly ineffective in secondary prevention of myocardial infarction .
C0038742
sulfinpyrazone
C0027051
myocardial